This session will provide an overview of the Canadian Access to Cannabis for Medical Purposes Regulations (ACMPR): history, status, implications for practitioners and providers, and opportunities for research and pharmacosurveillance. Issues around patient communication, screening, monitoring and follow up will be discussed. The session will further review how the medical market was integrated into the regulated market established under I-502 in 2012. In 2015, Substitute Senate Bill 5052 was passed to create the integrated market. The new system allows for additional benefits for patients and their designated providers not previously available. Case-based scenarios will assist attendees in understanding this complex law.
Medical Cannabis in Canada: Challenges and Opportunities
Mark A. Ware, MD MSc
Integrating Medical Marijuana into a Recreational Market: The Washington State Experience
Chris Baumgartner, BS
- Review Washington laws and rules regarding medical marijuana.
- Explain how to assist a patient in receiving authorization for use and a recognition card.
- Recognize all the additional benefits available to a patient in the regulated market.
- Discuss Canadian medical cannabis regulations and practice considerations.